Chronic Pain Treatment
NIH NEWS IN HEALTH
NIH News in Health · Source article
Pain can affect people in different ways. It can feel sharp or dull or like a prick, tingle, sting, burn, or ache. You may feel it in one area of your body or all over. Pain can be short-lived or go on for months or years.
Pain that lasts longer than three months is called chronic pain. Chronic pain can affect all aspects of daily life, including your mood, sleep, work, and relationships. And millions of Americans experience it.
Finding what works best to ease your chronic pain is a process. Treatments may include pain medications, medical procedures, devices, and physical therapy. Some people use complementary health options alongside conventional care. These may include acupuncture, yoga, chiropractic care, massage therapy, or tai chi.
But what’s available doesn’t always work for everyone. Sometimes, treatments may not get rid of pain, but they can still reduce pain and help people function better. Some pain medications have unwanted side effects. Others may lead to addiction.
Researchers are continuing to explore new ways to treat chronic pain. They’re looking for safer medications and more targeted therapies.
Developing Safer Medications
One class of drugs often used to treat pain is called opioids. Opioid drugs can lessen the feeling of pain in one part of the body or throughout the body. However, they can also cause serious side effects, including overdose and death. The risk is greater when opioids are misused or taken in ways other than prescribed. They can also lead to addiction for some people. Because these risks are widely recognized, opioid prescriptions have been declining in recent years.
“Doctors are less inclined to prescribe opioids for good reasons, but that means that some patients’ pain isn’t effectively treated,” says Dr. Steven Olson, a medicinal chemist at Sanford Burnham Presbys.
Olson and other researchers are trying to develop non-opioid drugs to relieve pain. “Our goal is to find an effective non-opioid drug that people can rely on and not be a danger to them,” Olson says.
Opioid pain relievers work by attaching to proteins called opioid receptors. Opioid receptors belong to a protein family called G protein-coupled receptors. When activated, they trigger signals inside cells that cause different effects in the body. These effects include pain relief.
Researchers have found that other types of G protein-coupled receptors can also bring pain relief. One example is neurotensin receptor 1. It’s activated by a molecule called neurotensin. But drugs that mimic neurotensin can also cause unwanted side effects. These include severe drops in body temperature and high blood pressure.
Olson and his team have discovered two molecules that can fine-tune the receptor’s response. These molecules stimulate the pain-relieving effects while reducing unwanted side effects. The team is now designing and making hundreds of new molecules to find more that can do both.
“We’re trying to develop the next generation of neurotensin receptor 1 drug molecules,” he says. Olson hopes to find molecules that they can develop into a new pain-relieving drug.
Targeted Pain Relief
Scientists are also testing a different approach to pain relief: gene therapy. Gene therapy delivers healthy genes into cells or fixes damaged genes in cells.
Dr. William Renthal is a neurology expert at Brigham and Women’s Hospital and Harvard Medical School. His team is developing new strategies to deliver gene therapies to specific nerve cells involved in pain.
Renthal’s team first created a cellular map of all the nerve cells in structures along the spine called the dorsal root ganglia. These contain nerve cells that carry sensory information from the body to the spinal cord. Some carry information about temperature or touch. Others carry pain signals from an injury or tissue damage. Those that carry pain signals are called nociceptors.
“We’ve used these maps to identify unique features about nociceptors,” Renthal explains. Those features help researchers design gene therapies that focus on the nerve cells that send pain signals. The goal is to avoid affecting nerves that control other sensations, such as touch.
“We want to be able to turn off the pain-transmitting signals without affecting the other cells in your body,” Renthal adds. Sending treatment only to pain-sensing nerve cells may help avoid unwanted side effects.
Complementary Health Options
Scientists are also looking beyond medicines for managing pain. Research has shown that certain complementary health approaches reduce pain for some people. These include acupuncture, massage therapy, tai chi, and others.
A recent study showed that nearly 1 out of every 2 people use complementary approaches for pain. Researchers are studying several complementary approaches for different types of pain.
Acupuncture is one example. It uses thin needles that are inserted through the skin into specific points on the body. The practice has been part of traditional Chinese medicine for centuries. One condition that acupuncture is being studied for as a form of pain relief is angina. Angina is a type of chest pain brought on by physical exertion or mental or emotional stress.
Researchers are looking at other complementary approaches to reduce pain caused by cancer treatment. Chemotherapy can damage nerves in the hands and feet. This leads to pain, numbness, tingling, loss of balance, and falls. Studies have shown that tai chi can improve balance and help lower the risk of falls. Tai chi involves slow, gentle movements and controlled breathing. Yoga also combines physical poses, breathing techniques, and meditation. Both approaches are being tested to help ease nerve pain from chemotherapy.
Pain often needs to be treated with a range of strategies because it affects the body in so many ways. At NIH’s chronic pain clinic, patients are evaluated and treated by a team of specialists.
“When patients come to the clinic, they’re seen by the entire team, including neurologists, nutritionists, psychologists, social workers, physical therapists, and rehabilitation medicine specialists,” says NIH’s Dr. Miroslav Bačkonja, an expert on pain treatment. “Our approach to assessing and treating chronic pain is to take a whole-person perspective.”
Complementary health options are part of this whole-person approach. For example, Bačkonja explains, “A patient might see a recreational therapist and get recommendations to learn tai chi, yoga, boxing, or dancing to improve their symptoms and function.” People with chronic pain may see a nutritionist to discuss changes to their diet or herbal options, in addition to other specialists on the team.
“We know there’s more to chronic pain than a single disease, joint, or incident,” he adds. Researchers are continuing to look for new options to help manage pain. If you’re dealing with chronic pain, talk with your doctor about treatment options. The options will differ depending on what’s causing the pain. Often, there are non-opioid treatment options that can improve your pain relief and quality of life now.
Further reading and research references
- The U.S. Centers for Disease Control and Prevention
- Managing Pain: Moving Beyond Opioids
- Chronic Pain: In Depth
- Pain: You Can Get Help
- Pain
- Pain Research Center
- Pain: Considering Complementary Approaches
- Drugs of Abuse: Opioids
- Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic pain
- Designing allosteric modulators to change GPCR G protein subtype selectivity
- Harmonized cross-species cell atlases of trigeminal and dorsal root ganglia.
- Use of complementary health approaches overall and for pain management by US adults.
Illustrative archival photograph: National Cancer Institute / Unsplash, used under the Unsplash License. The people or equipment shown are not identified as participants in the research or interviews described here.
Medicines
View more
NIH News in Health · Source article Health Capsule Some medications affect your brain and nervous system. Side effects can include an increased risk of confusion, falls, and hospitalization. This risk is higher for people with dementia—a brain disorder that causes memory loss and difficulty thinking clearly. A new study showed that many people with dementia are taking medicines that may not be safe for them. Researchers studied medical records of about 4,800 people aged 65 and older. They looked at how many people took at least one medicine that can affect the brain and nervous system for at least 28 days. The medicines included certain drugs that treat depression, anxiety or panic attacks, and sleeping problems. They also looked at some drugs that cause drowsiness. The researchers wanted to understand who was taking these drugs and why. In people with dementia, 25% took at least one of these medicines. Only 17% of people without dementia took one of these medications. The findings show that many older adults may be taking medications that might not be safe for them. Many did not have a medical reason to use them. Lowering the use of these medications could lead to better, safer care. But prescriptions that affect the brain and nervous system may sometimes be needed. “It is important for older patients and their caregivers to work closely with their physicians to ensure that these medications are appropriate to their cases,” says Dr. Annie Yang of Yale University. Source: NIH News in Health. Originally published April 2026. Republished by Graymedy on 11 October 2026. This is a sourced NIH article, not a Graymedy interview or original study. Read the original article and its research references. NIH News in Health permits republication of its articles and illustrations with acknowledgement. Research findings retain their original study context. Further reading and research references Dealing With Dementia: When Thinking and Behavior Decline What Is Dementia? Symptoms, Types, and Diagnosis Dementias Alzheimer’s Disease & Related Dementias Forgetfulness: Knowing When to Ask for Help Understanding Alzheimer's Disease NIH's Alzheimer's Disease Research Centers Prescribing patterns of potentially inappropriate CNS-active medications in older adults Illustrative archival photograph: National Cancer Institute / Unsplash, used under the Unsplash License. The people or equipment shown are not identified as participants in the research or interviews described here.
Fewer Newborns Receiving Protective Vitamin Shot
Coping With Chemo
Probing Aspirin’s Benefits
NIH News in Health · Source article Health Capsule Scientists have found ways to fix faulty genes for some common genetic disorders. These include sickle cell disease, various blood disorders, and a severe skin condition. But treating rarer genetic conditions has been more challenging. A new NIH-funded study used a personalized gene-editing approach in a baby born with a rare, often deadly disorder. The baby had a disease called CPS1 deficiency. People with this disease don’t have the enzyme that removes harmful ammonia from the body. About half of babies with CPS1 deficiency die as infants. The research team had spent years creating personalized therapies for people with similar disorders. So they were ready when the newborn showed symptoms of CPS1 deficiency. The team quickly crafted an experimental gene therapy. The baby received two treatments around the time he was six months old. A few weeks later, he needed less medication to keep ammonia levels in check. And his diet could include more protein. Protein intake can lead to ammonia buildup in kids with untreated CPS1 deficiency. No serious side effects were seen. But follow-up will be needed to be sure the therapy remains safe and effective. With further study, this type of personalized gene therapy could help to treat a variety of disorders. “Years and years of progress in gene editing and collaboration between researchers and clinicians made this moment possible,” says Dr. Rebecca Ahrens-Nicklas of the Children’s Hospital of Philadelphia, who helped lead this study. Source: NIH News in Health. Originally published July 2025. Republished by Graymedy on 11 October 2026. This is a sourced NIH article, not a Graymedy interview or original study. Read the original article and its research references. NIH News in Health permits republication of its articles and illustrations with acknowledgement. Research findings retain their original study context. Further reading and research references Carbamoyl Phosphate Synthetase 1 Deficiency Disease About Inborn Errors of Metabolism What Is Genome Editing? Patient-specific in vivo gene editing to treat a rare genetic disease. Illustrative archival photograph: National Cancer Institute / Unsplash, used under the Unsplash License. The people or equipment shown are not identified as participants in the research or interviews described here.
Treatment May Help Youth Quit Vaping